Grant Private Wealth Management’s AbbVie ABBV Stock Holding History

Grant Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$623K	Sell	2,380 -2,272	-49%	-$582K	0.28%	80
2026 Q2	$1.17M	Buy	4,652 +530	+13%	+$114K	0.49%	38
2026 Q1	$897K	Buy	4,122 +907	+28%	+$201K	0.48%	47
2025 Q4	$735K	Buy	3,215 +300	+10%	+$68.3K	0.44%	46
2025 Q3	$675K	Sell	2,915 -8,979	-75%	-$1.83M	0.42%	51
2025 Q2	$2.21M	Buy	11,894 +9,514	+400%	+$1.77M	1.25%	27
2025 Q1	$499K	Buy	2,380 +686	+40%	+$133K	0.54%	53
2024 Q4	$301K	Buy	+1,694	New	+$311K	0.32%	85

Other funds holding ABBV

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Grant Private Wealth Management's ABBV Position: Q3 2026 in Review

Grant Private Wealth Management reduced its AbbVie (ABBV) stake by 49% in Q3 2026, selling an estimated $582K and leaving 2,380 shares worth $623K. The position accounts for 0.28% of the portfolio, ranked #80.

Grant Private Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.21M in Q2 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Grant Private Wealth Management held 2,380 shares of AbbVie worth $623K as of Q3 2026.
Grant Private Wealth Management sold 2,272 AbbVie shares in Q3 2026, an estimated $582K.
AbbVie made up 0.28% of Grant Private Wealth Management's portfolio in Q3 2026, its #80 holding.
Grant Private Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
Grant Private Wealth Management's AbbVie position peaked at $2.21M in Q2 2025.
3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Grant Private Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.